Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Wall Street The pharmaceutical giant's stock has reached a 13-figure capitalisation and now trades at one of the highest valuations in the entire pharmaceutical sector, at around 50 times expected earnings over the next 12 months Pharmaceutical giant Eli Lilly has reached $1 trillion in market capitalisation, becoming the first company in the industry to enter the small club of companies valued at 13 figures, hitherto dominated by technology giants such as Apple, Microsoft, Nvidia, Alphabet, Amazon, Meta, Tesla, Broadcom and Berkshire Hathaway
HermanGAStevensCVan DyckKBergmanAYiBDe SmetMet al
Comparison to Current Medications Current GLP 1 medications provide a baseline for cost expectations
However, these medications are approved for type 2 diabetes and chronic weight management, and clinical trials demonstrate significant improvements in liver fat content and inflammation
Effective LOE dates are subject to change based on litigation outcomes, settlement agreements, and regulatory decisions
Retatrutide (say that 3 times fast) is demonstrating just jaw-dropping rates of weight loss
